Feeling about watching the live broadcast with goods
Release time:
2020-11-03
View Live with Goods Feeling
Live with Goods has developed into a new industry in the new era, showing a strong explosion, and is creating a new market of hundreds of billions. During the new coronary pneumonia epidemic, offline retailing was affected, live streaming with goods heated up again, live streaming has become a group behavior with the participation of the whole people, and even an online entertainment activity, who watched the live broadcast and what to buy has become a topic.
1. celebrity effect traffic is king.
Live delivery breaks the time and space restrictions and has a wider dissemination effect. In this era when traffic is king, celebrities and Internet celebrities bring their own halos to endorse the value of the goods they bring. These are all ways to embrace the Internet, seize the economic opportunities of live broadcast and boost consumer confidence. In addition to the stars, there are many of the usual "dragon sees the head but not the tail" business bosses, such as Robin Li, Zhang Chaoyang, Dong Mingzhu, etc. Even Ma Yun once challenged Li Jiaqi to sell lipstick live at the same time. It can be said that all walks of life are now aiming at live delivery. In addition to corporate bosses and even local officials and cadres into the live broadcast room to bring goods live, to deal with the impact of the epidemic on industrial poverty alleviation. For example, Song Junhua, deputy head of Zigui County, Hubei Province, brought a local specialty navel orange. On the afternoon of the first day of Wuhan's unsealing, Wuhan's vice mayor Li Qiang and entrepreneurs and talent started the first live show to promote Wuhan's special products such as good products shop, Cai Linji, Qianji cake and Zhou Heiya.
2. live delivery cannot be "disaster".
There is no doubt that live delivery has become the hottest marketing method for major e-commerce platforms. Especially during the epidemic. However, the "rollover" incident in the live delivery has occurred frequently, bringing a lot of troubles to consumers. Price concessions are definitely a great weapon for live delivery. Some professional anchors negotiated with suppliers to win the "lowest price in the whole network" and "no middlemen to earn the difference", so that consumers can enjoy real preferential prices. The price is favorable, but there are hidden worries about quality and service. Some anchors exaggerate when recommending a product, and the product is seriously inconsistent with the publicity. Some so-called explosive items have quality problems, and some are even "three no products"; Some platforms have fake live broadcast data, misleading consumers; There are also platforms that are sold live and there is no guarantee after sale. "Non-stick pan" into "no! Sticky pan", the Yangcheng Lake "bath crab" said Yangcheng Lake hairy crabs, a brand of crayfish has been punished for publishing false advertising, a cosmetics brand has also been fined for not clearly explained the goods. These "rollover" incidents have directly changed from "bringing goods" to "bringing disaster", which has overdrawn the trust of consumers.
3. the protection of consumers' rights and interests in live delivery.
The China Consumers Association combed consumer complaints and found that some anchors had exaggerated publicity when bringing goods, some consumers encountered fake and inferior goods, and after-sales service was difficult to guarantee. The relationship between sellers and platforms, and between live broadcast platforms and e-commerce trading platforms was complicated, which greatly reduced consumers' right to know, fair trading rights and reasonable rights protection demands. According to statistics from the China Consumers Association, 37.2 of the respondents have encountered consumption problems in live shopping. "Worrying about the quality of goods is not guaranteed" and "worrying about after-sales problems" are the two main concerns of consumers. E-commerce live broadcast involves issues such as corporate registration laws, advertising laws, product quality laws, consumer rights protection laws, e-commerce laws, food safety laws, and price laws. Since e-commerce live broadcast is immediate, the relevant regulatory authorities should have corresponding technical means to solve the problem of consumers' difficulty in obtaining evidence. The essence of live delivery is the product, not the anchor. At the same time, how to ensure product quality and after-sales service, and how to protect the rights and interests of consumers have become an urgent problem to be solved by the relevant departments.
Thinking about live delivery of 4.
Live delivery is so popular that it seems that nothing can't be sold, but it is incompatible with the pharmaceutical industry. The pharmaceutical industry has its particularity, that is, the sales of products cannot be sold directly to consumers by manufacturers or distributors, but need to be sold to consumers through medical institutions and doctors' diagnosis and treatment and prescriptions. This is doomed to pharmaceutical products and live with goods. And the efficacy of drugs requires feedback from the market, doctors and consumers, not the celebrity traffic effect. Therefore, workers in our pharmaceutical industry need not blindly envy and admire live delivery. Instead, we should do our job well. We should be rigorous and professional in all aspects of R & D, production and sales, so as to produce and sell the safest and most effective drugs to consumers and bring good news to the common people.
Under the background of "internet plus", live delivery is a severe test to adapt to the new situation and new environment and learn new knowledge and skills. The Internet is fast-paced, and the pharmaceutical industry is slow-paced. When the two are combined with each other, they cannot achieve organic integration, and there will be problems in many aspects. At this time, the fast features of the Internet are not desirable in the pharmaceutical industry. Once you come to the pharmaceutical industry with a "fast" mentality, it may cause very serious consequences and even endanger the lives of consumers. The pharmaceutical industry is an industry that requires a long time of accumulation to upgrade. Therefore, the pharmaceutical industry should learn and learn from what is available behind the popularity of live delivery, instead of leaving behind the stability and rigor of the traditional industry. (Sheng Da)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31